Skip to main content
. 2014 Nov 4;2014:364549. doi: 10.1155/2014/364549

Table 1.

Associations of miR-15a and/or miR-16 expression with the clinicopathological characteristics of colorectal cancer.

Clinical features Case number (%) miR-15a-low miR-16-low miR-15a-low/miR-16-low
(N, %) P (N, %) P (N, %) P
Gender
 Male 76 (60.32) 42 (55.26) NS 45 (59.21) NS 32 (42.11) NS
 Female 50 (39.68) 31 (62.00) 31 (62.00) 21 (42.00)
Age (years)
 <66 48 (30.10) 32 (66.67) NS 32 (66.67) NS 22 (45.83) NS
 ≥66 78 (69.90) 41 (52.56) 44 (56.41) 31 (39.74)
Site of primary tumor
 Right-sided 48 (38.10) 30 (62.50) NS 30 (62.50) NS 22 (45.83) NS
 Left-sided 46 (36.51) 26 (56.52) 26 (56.52) 20 (43.48)
 Rectum 32 (25.40) 17 (53.13) 20 (62.50) 11 (34.38)
Tumor size (cm)
 <5 70 (55.56) 42 (60.00) NS 42 (60.00) NS 32 (45.71) NS
 ≥5 56 (44.44) 31 (55.36) 34 (60.71) 21 (37.50)
Depth of tumor invasion
 T1-T2 47 (37.30) 30 (63.83) NS 30 (63.83) NS 20 (42.55) NS
 T3-T4 79 (62.70) 43 (54.43) 46 (58.23) 33 (41.77)
Lymph node metastasis
 Negative 68 (53.97) 29 (42.65) 0.01 29 (42.65) 0.01 13 (19.12) 0.008
 Positive 58 (46.03) 44 (75.86) 47 (81.03) 40 (68.97)
TNM stage
 I 13 (10.32) 3 (23.08) 0.001 3 (23.08) 0.001 0 (0) <0.001
 II 46 (36.51) 17 (36.96) 20 (43.48) 10 (18.87)
 III 50 (39.68) 36 (72.00) 36 (72.00) 26 (52.00)
 IV 17 (13.49) 17 (100.00) 17 (100.00) 17 (100.00)
Histological grade
 Well/moderately 80 (63.49) 40 (50.00) 0.02 40 (50.00) 0.02 23 (28.75) 0.01
 Poorly 46 (36.51) 33 (71.74) 36 (78.26) 30 (65.22)

Note: “NS” refers to the difference without statistical significance.